- Home
- BIVI vs ADGM Comparison
BIVI vs ADGM Comparison
Compare BIVI & ADGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIVI
- ADGM
- Stock Information
- Founded
- BIVI 2013
- ADGM 2011
- Country
- BIVI United States
- ADGM United States
- Employees
- BIVI N/A
- ADGM N/A
- Industry
- BIVI Biotechnology: Pharmaceutical Preparations
- ADGM
- Sector
- BIVI Health Care
- ADGM
- Exchange
- BIVI Nasdaq
- ADGM NYSE
- Market Cap
- BIVI 18.6M
- ADGM 19.7M
- IPO Year
- BIVI N/A
- ADGM N/A
- Fundamental
- Price
- BIVI $1.08
- ADGM $1.27
- Analyst Decision
- BIVI Strong Buy
- ADGM
- Analyst Count
- BIVI 1
- ADGM 0
- Target Price
- BIVI $30.00
- ADGM N/A
- AVG Volume (30 Days)
- BIVI 282.1K
- ADGM 68.2K
- Earning Date
- BIVI 05-12-2025
- ADGM 05-15-2025
- Dividend Yield
- BIVI N/A
- ADGM N/A
- EPS Growth
- BIVI N/A
- ADGM N/A
- EPS
- BIVI N/A
- ADGM N/A
- Revenue
- BIVI N/A
- ADGM $576,000.00
- Revenue This Year
- BIVI N/A
- ADGM N/A
- Revenue Next Year
- BIVI N/A
- ADGM N/A
- P/E Ratio
- BIVI N/A
- ADGM N/A
- Revenue Growth
- BIVI N/A
- ADGM 116.54
- 52 Week Low
- BIVI $0.62
- ADGM $0.63
- 52 Week High
- BIVI $7.50
- ADGM $9.34
- Technical
- Relative Strength Index (RSI)
- BIVI 53.42
- ADGM N/A
- Support Level
- BIVI $1.07
- ADGM N/A
- Resistance Level
- BIVI $1.13
- ADGM N/A
- Average True Range (ATR)
- BIVI 0.06
- ADGM 0.00
- MACD
- BIVI 0.00
- ADGM 0.00
- Stochastic Oscillator
- BIVI 65.99
- ADGM 0.00
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
About ADGM ADAGIO MEDICAL HOLDINGS INC
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for the treatment of cardiac arrhythmias. The company focuses on developing cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.